| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eli Lilly & Co (LLY) has 20 insiders with recent SEC Form 4 filings, including 1 buy and 26 sells. LLY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 92.18M | $101.59B | - | |
| CEO | 515.2K | $567.75M | - | |
| VP | 137.5K | $151.52M | - | |
| Dir | 75.1K | $82.77M | - | |
| Dir | 55.5K | $61.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $350.49 | $73,603,586.59 | - | +31.6% | +117.8% | |
| Mar 31, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $342.01 | $70,111,869.48 | - | +35.3% | +121.5% | |
| Mar 24, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $335.82 | $67,164,554.71 | - | +36.2% | +129.3% | |
| Mar 10, 2023 | Weems Alonzo | EVP, Erm &Ceco | Sell | 1,000 | $318.85 | $318,850.00 | -10.1% | +41.5% | +141.9% | |
| Feb 27, 2023 | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 600 | $322.47 | $193,482.00 | -8.4% | +34.9% | +141.6% | |
| Feb 13, 2023 | White Anne E. | EVP &Pres, Lilly Neuroscience | Sell | 5,000 | $344.62 | $1,723,075.00 | -4.1% | +24.0% | +112.0% | |
| Dec 2, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 49,089 | $372.88 | $18,304,192.32 | - | -15.9% | +55.8% | |
| Dec 1, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 160,911 | $371.54 | $59,785,492.55 | - | -15.2% | +57.7% | |
| Nov 30, 2022 | Kearny Acquisition Corp | 10% Owner | Buy | 29,992,668 | $12.50 | $374,908,350.00 | -100.0% | -16.1% | +59.3% | |
| Nov 7, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 63,585 | $363.94 | $23,141,043.50 | - | -7.3% | +64.8% |